Abstract
The tonic discharge of 71 medial vestibular nucleus (MVN) neurones was recorded in slices of the dorsal brainstem of young adult rats. Bath application of histamine caused a dose-related excitation in 59 of the 71 cells (83%), the remaining 12 (17%) being unresponsive. Dimaprit, a selective H2 agonist, also caused excitation in all 20 cells tested. The histamine-induced excitation and the response to dimaprit were antagonised by the selective H2 antagonist ranitidine, confirming that the H2 subtype of histamine receptor is involved in mediating the effects of histamine on these cells. Triprolidine, a selective H1 antagonist, also antagonised the excitation caused by histamine, at a concentration (0.3 μM) which left the H2 receptor-mediated response to dimaprit unchanged. Thus the excitatory effects of histamine on MVN cells in the rat involve two components mediated through H1 and H2 receptor-linked mechanisms, respectively. Betahistine, a weak H1 agonist and H3 antagonist, had little excitatory action when applied on its own, but significantly reduced the excitation caused by histamine when the two drugs were applied together. The effects of betahistine were consistent with a partial-agonist action at H1 receptors on MVN cells, reducing the excitatory responses to histamine presumably by occupying these receptor sites in competition with the exogenously applied neurotransmitter. This partial-agonist action of betahistine may be an important part of its mechanism of action in the symptomatic treatment of vertigo and motion sickness, since it is likely to occur not only in the MVN but also in many brain regions, including the thalamus and cortex, which express H1 receptors and which are innervated by the hypothalamic histaminergic system. Thus the effectiveness of betahistine and other anti-H1 drugs against motion sickness may be explained by their action in reducing the effects of the excess histamine release induced in such conditions in various brain areas, including the MVN.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Al-Gadi M, Hill SJ (1985) Characterisation of histamine receptors mediating the stimulation of cyclic AMP accumulation in rabbit cerebral cortical slices. Br J Pharmacol 85: 877–888
Arrang JM, Garbarg M, Schwartz JC (1983) Autoinhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302: 832–837
Arrang JM, Garbarg M, Schwartz JC (1985a) Autoregulation of histamine release in brain by presynaptic H3 receptors. Neuroscience 15: 553–562
Arrang JM, Grabarg M, Quach TT, Tuong MDT, Yeramian E, Schwartz JC (1985b) Action of betahistine and histamine receptors in the brain. Eur J Pharmacol 111: 73–84
Balaban CD, Beryozkin G (1994) Vestibular nucleus projections to nucleus tractus solitarius and dorsal motor nucleus of the vagus nerve — potential substrates for vestibule-autonomic interactions. Exp Brain Res 98: 200–212
Brandt T (1991) Vertigo: its multisensory syndromes. Springer, London, pp 1–24
Bouthenet ML, Ruat M, Sales N, Garbarg M, Schwartz JC (1988) A detailed mapping of histamine H1, receptors in guinea-pig central nervous system established by autoradiography with [125I]iodobolpyramine. Neuroscience 26: 553–600
Calcutt CR, Ganellin CR, Griffiths R, Leigh BK, Maguire JP, Mitchell RC, Mylek ME, Parsons ME, Smith IR, Young RC (1988) Zolantidine (SK&F 95282) is a potent selective brain penetrating histamine H2 receptor antagonist. Br J Pharmacol 93: 69–78
Dutia MB, Johnston AR, McQueen DS (1992) Tonic activity of rat medial vestibular nucleus neurones in vitro and its inhibition by GABA. Exp Brain Res 88: 466–472
Fleckenstein AR, Lookingland KJ, Moore KE (1994) Histaminergic neurons mediate restraint stress-induced increases in the activity of noradrenergic neurons projecting to the hypothalamus. Brain Res 653: 273–277
Fisher AJEM (1991) Histamine in the treatment of vertigo. Acta Otlaryngol (Stockh) [Suppl] 479: 24–28
Hill SJ (1990) Distribution, properties and functional characteristics of three classes of histamine receptor. Pharmacol Rev 42: 45–83
Horii A, Takeda N, Matsunaga T, Yamatodani A, Mochizuki T, Okakura-Mochizuki K, Wada H (1993) Effect of unilateral vestibular stimulation on histamine release from the hypothalamus of rats in vivo. J Neurophysiol 70: 1822–1826
Inverarity DJ, Johnston AR, McQueen DS, Dutia MB (1993) Effects of histamine on rat medial vestibular nucleus neurones in vitro (abstract). J Physiol (Lond) 459: 466
Johnston AR, Murnion B, McQueen DS, Dutia MB (1993) Excitation and inhibition of rat medial vestibular nucleus neurones by 5-hydroxytryptamine. Exp Brain Res 93: 293–298
Johnston AR, MacLeod NK, Dutia MB (1994) Ionic conductances contributing to spike repolarisation and afterpotentials in rat medial vestibular nucleus neurones. J Physiol (Lond) 481: 61–77
Laurikainen EA, Miller JM, Quirk WS, Kallinen J, Ren T, Nuttall AL, Grenman R, Virolainen E (1993) Betahistine-induced vascular effects in the rat cochlea. Am J Otol 14: 24–30
Matsuoka I, Ito J, Takahashi H, Sasa M, Takaori S (1985) Experimental vestibular pharmacology: a minireview with special reference to neuroactive substances and antivertigo drugs. Acta Otolaryngol (Stockh) [Suppl] 419: 62–70
Palacios JM, Garbarg M, Barbin G, Schwartz JC (1978) Pharmacological characterisation of histamine receptors mediating the stimulation of cyclic AMP accumulation in slices from guineapig hippocampus. Mol Pharmacol 14: 971–982
Panula P, Pirvola U, Auvinen S, Airaksinen MS (1989) Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience 28: 585–610
Phelan KD, Nakamura J, Gallagher JP (1990) Histamine depolarises rat medial vestibular nucleus neurons recorded intracellularly in vitro. Neurosci Lett 109: 287–292
Ruat M, Traiffort E, Arrang JM, Leurs R, Schwartz JC (1991) Cloning and tissue expression of a rat histamine H2 receptor gene. Biochem Biophys Res Comm 179: 1470–1478
Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M (1991) Histaminergic transmission in the mammalian brain. Physiol Rev 71: 1–51
Serafin M, Khateb A, Vibert N, Vidai PP, Muhlethaler M (1993) Medial vestibular nucleus in the guinea pig: histaminergic receptors. I. An in vitro study. Exp Brain Res 93: 242–248
Steinbusch HWM (1991) Distribution of histaminergic neurons and fibers in rat brain. Acta Otolaryngol (Stockh) [Suppl] 479: 12–23
Takeda N, Morita M, Kubo T, Yamatodani A, Watanabe T, Wada H, Matsunaga T (1986) Histaminergic mechanisms of motion sickness: neurochemical and neuropharmacological studies in rats. Acta Otolaryngol 101: 416–421
Takeda N, Morita M, Hasegawa S, Kubo T, Matsunaga T (1989) Neurochemical mechanisms of motion sickness. Am J Otolaryngol 10: 351–359
Takeda N, Morita M, Hasegawa S, Horii A, Kubo T, Matsunaga T (1993) Neuropharmacology of motion sickness and emesis -a review. Acta Otolaryngol (Stockh) [Suppl] 501: 10–15
Yabe T, Waele C de, Serafin M, Vibert N, Arrang JM, Muhlethaler M, Vidal PP (1993) Medial vestibular nucleus in the guinea pig: histaminergic receptors. IL An in vivo study. Exp Brain Res 93: 249–258
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, J.J., Dutia, M.B. Effects of histamine and betahistine on rat medial vestibular nucleus neurones: possible mechanism of action of anti-histaminergic drugs in vertigo and motion sickness. Exp Brain Res 105, 18–24 (1995). https://doi.org/10.1007/BF00242178
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00242178